5-ASA, corticosteroids, thiopurine, and TNF-α blockers, which are extensively used to treat IBD in clinical practice, were verified by large cohort studies to significantly reduce or delay the requirement for major surgeries [9–12]. This evidence concerns the gene TNF and inflammatory bowel disease.